Cell and gene therapy venture funding deal count year-over-year change vs Sales growth at constant exchange rates
Cell and gene therapy venture funding deal count year-over-year change and Sales growth at constant exchange rates worldwide, compared over time.
Change the pair
Compare different indicators
The series
Over time
Global, spaced by time. Both series are in %, so they share one axis; the legend names each line.
Cell and gene therapy venture funding deal count year-over-year change and Sales growth at constant exchange rates
Unit: % · 5 observations
View the underlying data
| Indicator | Period | Type | Value |
|---|---|---|---|
| Cell and gene therapy venture funding deal count year-over-year change | 2023 | Actual | 19% |
| Cell and gene therapy venture funding deal count year-over-year change | 2022 | Actual | -24% |
| Cell and gene therapy venture funding deal count year-over-year change | 2021 | Actual | 57% |
| Sales growth at constant exchange rates | Q2 2026 | Actual | 17.8% |
| Sales growth at constant exchange rates | Q1 2026 | Actual | 3% |
Provenance
Where these numbers come from
Cell and gene therapy venture funding deal count year-over-year change
Percentage change in the number of cell and gene therapy venture capital and public funding deals versus the prior year.
3 observations in Global · source organisations: IQVIA
Sales growth at constant exchange rates
Percentage change in sales calculated at constant exchange rates over the specified period.
2 observations in Global · source organisations: Roche, Sanofi
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring